Dacai Xu
Zhanjiang, 524033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: February 27, 2025
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.
Journal: Oncogene
Published: February 26, 2025
UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma.
Journal: Free radical biology & medicine
Published: January 28, 2025
Autophagy Induced by Proteasomal DUB Inhibitor NiPT Restricts NiPT-Mediated Cancer Cell Death.
Journal: Frontiers in oncology
Published: October 15, 2019
Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: March 30, 2018
Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
Journal: European journal of pharmacology
Published: April 15, 2017
Bilirubin neurotoxicity is associated with proteasome inhibition.
Journal: Cell death & disease
Published: January 16, 2017
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
Journal: Molecular medicine reports
Published: December 17, 2014
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
Journal: Molecular medicine reports
Published: December 17, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026